Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, Canada,
Intensive Care Med. 2015 Jun;41(6):994-1003. doi: 10.1007/s00134-015-3716-2. Epub 2015 Mar 10.
In patients with acute respiratory distress syndrome (ARDS), extracorporeal life support (ECLS) has been utilized to support gas exchange and mitigate ventilator-induced lung injury (VILI). The optimal ventilation settings while on ECLS are unknown. The purpose of this systematic review is to describe the ventilation practices in patients with ARDS who require ECLS.
We electronically searched MEDLINE, EMBASE, CENTRAL, AMED, and HAPI (inception to January 2015). Studies included were randomized controlled trials, observational studies, or case series (≥4 patients) of ARDS patients undergoing ECLS. Our review focused on studies describing ventilation practices employed during ECLS for ARDS.
Forty-nine studies (2,042 patients) met our inclusion criteria. Prior to initiation of ECLS, at least one parameter consistent with injurious ventilation [tidal volume >8 mL/kg predicted body weight (PBW), peak pressure >35 cmH2O (or plateau pressure >30 cmH2O), or FiO2 ≥0.8] was noted in 90% of studies. After initiation of ECLS, studies reported median [interquartile range (IQR)] reductions in: tidal volume [2.4 mL/kg PBW (2.2-2.9)], plateau pressure [4.3 cmH2O (3.5-5.8)], positive end-expiratory pressure (PEEP) [0.20 cmH2O (0-3.0)], and FiO2 [0.40 (0.30-0.60)]. Median (IQR) overall mortality was 41 % (31-51%).
Reduction in the intensity of mechanical ventilation in patients with ARDS supported by ECLS is common, suggesting that clinicians may be focused on reducing VILI after ECLS initiation. Future investigations should focus on establishing the optimal ventilatory strategy for patients with ARDS who require ECLS.
在急性呼吸窘迫综合征(ARDS)患者中,体外生命支持(ECLS)已被用于支持气体交换和减轻呼吸机引起的肺损伤(VILI)。在 ECLS 时的最佳通气设置尚不清楚。本系统评价的目的是描述需要 ECLS 的 ARDS 患者的通气实践。
我们电子检索了 MEDLINE、EMBASE、CENTRAL、AMED 和 HAPI(从开始到 2015 年 1 月)。纳入的研究为 ARDS 患者接受 ECLS 的随机对照试验、观察性研究或病例系列研究(≥4 例)。我们的综述重点是描述 ARDS 患者在 ECLS 期间使用的通气实践的研究。
49 项研究(2042 例患者)符合我们的纳入标准。在开始 ECLS 之前,90%的研究中至少有一个参数与损伤性通气一致[潮气量>8ml/kg 预测体重(PBW),峰压>35cmH2O(或平台压>30cmH2O),或 FiO2≥0.8]。在开始 ECLS 后,研究报告了中位数[四分位距(IQR)]的降低:潮气量[2.4ml/kg PBW(2.2-2.9)],平台压[4.3cmH2O(3.5-5.8)],呼气末正压(PEEP)[0.20cmH2O(0-3.0)]和 FiO2[0.40(0.30-0.60)]。中位数(IQR)总死亡率为 41%(31-51%)。
在接受 ECLS 支持的 ARDS 患者中,机械通气强度降低很常见,这表明临床医生可能在 ECLS 启动后专注于降低 VILI。未来的研究应集中于为需要 ECLS 的 ARDS 患者建立最佳通气策略。